$ARNA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARENA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ARENA PHARMACEUTICALS INC. Get notifications about new insider transactions in ARENA PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 ... 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Soni Manmeet Singh | Director | Sell | S | 60.12 | 1,327 | 79,779 | 6,206 | 7.5 K to 6.2 K (-17.62 %) |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Soni Manmeet Singh | Director | Grant | A | 0.00 | 2,446 | 0 | 7,533 | 5.1 K to 7.5 K (+48.08 %) |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Soni Manmeet Singh | Director | Option Exercise | A | 61.31 | 5,000 | 306,550 | 5,000 | |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Soni Manmeet Singh | Director | Sell | S | 60.12 | 1,327 | 79,779 | 6,206 | 7.5 K to 6.2 K (-17.62 %) |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Soni Manmeet Singh | Director | Grant | A | 0.00 | 2,446 | 0 | 7,533 | 5.1 K to 7.5 K (+48.08 %) |
Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 35.60 | 5,000 | 178,000 | 95,000 | |
Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 14.60 | 10,000 | 146,000 | 79,500 | |
Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 17.10 | 10,000 | 171,000 | 45,000 | |
Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Sell | S | 65.00 | 25,000 | 1,625,023 | 0 | 25 K to 0 (-100.00 %) |
Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 35.60 | 5,000 | 178,000 | 25,000 | 20 K to 25 K (+25.00 %) |
Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 14.60 | 10,000 | 146,000 | 20,000 | 10 K to 20 K (+100.00 %) |
Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 17.10 | 10,000 | 171,000 | 10,000 | 0 to 10 K |
Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | M | 15.50 | 41,861 | 648,846 | 338,139 | |
Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | M | 14.60 | 8,139 | 118,829 | 56,861 | |
Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | M | 14.60 | 50,000 | 730,000 | 65,000 | |
Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 69.26 | 17,962 | 1,244,014 | 7,750 | 25.7 K to 7.8 K (-69.86 %) |
Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 68.61 | 20,028 | 1,374,213 | 25,712 | 45.7 K to 25.7 K (-43.79 %) |
Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 67.36 | 12,010 | 809,009 | 45,740 | 57.8 K to 45.7 K (-20.80 %) |
Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | M | 15.50 | 41,861 | 648,846 | 57,750 | 15.9 K to 57.8 K (+263.46 %) |
Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | M | 14.60 | 8,139 | 118,829 | 15,889 | 7.8 K to 15.9 K (+105.02 %) |
Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 65.00 | 50,000 | 3,250,000 | 7,750 | 57.8 K to 7.8 K (-86.58 %) |
Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | M | 14.60 | 50,000 | 730,000 | 57,750 | 7.8 K to 57.8 K (+645.16 %) |
May 22 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | M | 14.60 | 34,800 | 508,080 | 115,000 | |
May 22 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | M | 14.60 | 50,000 | 730,000 | 149,800 | |
May 22 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 59.12 | 6,462 | 382,017 | 7,750 | 14.2 K to 7.8 K (-45.47 %) |
May 22 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 58.61 | 13,931 | 816,461 | 14,212 | 28.1 K to 14.2 K (-49.50 %) |
May 22 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 57.52 | 9,017 | 518,662 | 28,143 | 37.2 K to 28.1 K (-24.27 %) |
May 22 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 56.67 | 5,390 | 305,468 | 37,160 | 42.6 K to 37.2 K (-12.67 %) |
May 22 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | M | 14.60 | 34,800 | 508,080 | 42,550 | 7.8 K to 42.6 K (+449.03 %) |
May 22 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 55.00 | 50,000 | 2,750,000 | 7,750 | 57.8 K to 7.8 K (-86.58 %) |
May 22 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | M | 14.60 | 50,000 | 730,000 | 57,750 | 7.8 K to 57.8 K (+645.16 %) |
Mar 17 2020 | ARNA | ARENA PHARMACEUTIC ... | Stelzer Laurie | EVP & Chief Financi ... | Option Exercise | A | 0.00 | 6,300 | 0 | 6,300 | |
Mar 17 2020 | ARNA | ARENA PHARMACEUTIC ... | Stelzer Laurie | EVP & Chief Financi ... | Option Exercise | A | 36.33 | 132,000 | 4,795,560 | 132,000 | |
Mar 17 2020 | ARNA | ARENA PHARMACEUTIC ... | Schmidt Joan | EVP, General Counse ... | Option Exercise | A | 0.00 | 6,300 | 0 | 6,300 | |
Mar 17 2020 | ARNA | ARENA PHARMACEUTIC ... | Schmidt Joan | EVP, General Counse ... | Option Exercise | A | 36.33 | 132,000 | 4,795,560 | 132,000 | |
Feb 28 2020 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 14.90 | 7,970 | 118,753 | 0 | |
Feb 28 2020 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 14.90 | 7,970 | 118,753 | 17,437 | 9.5 K to 17.4 K (+84.19 %) |
Feb 14 2020 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 37.20 | 4,964 | 184,661 | 2,536 | |
Feb 14 2020 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 32.50 | 2,472 | 80,340 | 1,254 | |
Feb 14 2020 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 55.00 | 10,836 | 595,980 | 9,467 | 20.3 K to 9.5 K (-53.37 %) |
Feb 14 2020 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 37.20 | 4,964 | 184,661 | 20,303 | 15.3 K to 20.3 K (+32.36 %) |
Feb 14 2020 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 32.50 | 2,472 | 80,340 | 15,339 | 12.9 K to 15.3 K (+19.21 %) |
Feb 14 2020 | ARNA | ARENA PHARMACEUTIC ... | Lind Kevin Robert | Executive VP and CF ... | Option Exercise | M | 35.60 | 2,000 | 71,200 | 128,000 | |
Feb 14 2020 | ARNA | ARENA PHARMACEUTIC ... | Lind Kevin Robert | Executive VP and CF ... | Option Exercise | M | 19.40 | 2,500 | 48,500 | 77,500 | |
Feb 14 2020 | ARNA | ARENA PHARMACEUTIC ... | Lind Kevin Robert | Executive VP and CF ... | Sell | S | 55.00 | 4,500 | 247,500 | 3,457 | 8 K to 3.5 K (-56.55 %) |
Feb 14 2020 | ARNA | ARENA PHARMACEUTIC ... | Lind Kevin Robert | Executive VP and CF ... | Buy | M | 35.60 | 2,000 | 71,200 | 7,957 | 6 K to 8 K (+33.57 %) |
Feb 14 2020 | ARNA | ARENA PHARMACEUTIC ... | Lind Kevin Robert | Executive VP and CF ... | Buy | M | 19.40 | 2,500 | 48,500 | 5,957 | 3.5 K to 6 K (+72.32 %) |
Feb 14 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | M | 14.60 | 15,200 | 221,920 | 199,800 | |
Feb 14 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 55.00 | 15,200 | 836,000 | 7,750 | 23 K to 7.8 K (-66.23 %) |
Feb 14 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | M | 14.60 | 15,200 | 221,920 | 22,950 | 7.8 K to 23 K (+196.13 %) |
Feb 07 2020 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Sell | S | 50.00 | 9,000 | 450,000 | 0 | 9 K to 0 (-100.00 %) |
Feb 07 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 50.00 | 7,129 | 356,450 | 7,750 | 14.9 K to 7.8 K (-47.91 %) |
Nov 26 2019 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Sell | S | 45.83 | 4,429 | 203,000 | 0 | 4.4 K to 0 (-100.00 %) |
Nov 13 2019 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Option Exercise | M | 32.50 | 3,046 | 98,995 | 0 | |
Nov 13 2019 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Option Exercise | M | 32.50 | 3,046 | 98,995 | 0 | |
Nov 13 2019 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Sell | S | 46.73 | 3,046 | 142,340 | 14,230 | 17.3 K to 14.2 K (-17.63 %) |
Nov 13 2019 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Sell | S | 46.73 | 3,046 | 142,340 | 14,230 | 17.3 K to 14.2 K (-17.63 %) |
Nov 13 2019 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Buy | M | 32.50 | 3,046 | 98,995 | 17,276 | 14.2 K to 17.3 K (+21.41 %) |
Nov 13 2019 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Buy | M | 32.50 | 3,046 | 98,995 | 17,276 | 14.2 K to 17.3 K (+21.41 %) |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 6,300 | 0 | 18,900 | |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Payment of Exercise | F | 47.32 | 1,871 | 88,536 | 4,429 | 6.3 K to 4.4 K (-29.70 %) |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Buy | M | 0.00 | 6,300 | 0 | 6,300 | 0 to 6.3 K |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Option Exercise | M | 0.00 | 6,300 | 0 | 18,900 | |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Payment of Exercise | F | 47.32 | 2,309 | 109,262 | 3,991 | 6.3 K to 4 K (-36.65 %) |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Buy | M | 0.00 | 6,300 | 0 | 6,300 | 0 to 6.3 K |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 0.00 | 9,000 | 0 | 27,000 | |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 0.00 | 9,000 | 0 | 9,000 | 0 to 9 K |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | Lind Kevin Robert | Executive VP and CF ... | Option Exercise | M | 0.00 | 6,300 | 0 | 18,900 | |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | Lind Kevin Robert | Executive VP and CF ... | Payment of Exercise | F | 47.32 | 3,091 | 146,266 | 3,457 | 6.5 K to 3.5 K (-47.21 %) |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | Lind Kevin Robert | Executive VP and CF ... | Buy | M | 0.00 | 6,300 | 0 | 6,548 | 248 to 6.5 K (+2,540.32 %) |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | M | 0.00 | 11,700 | 0 | 35,100 | |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Payment of Exercise | F | 47.32 | 4,571 | 216,300 | 14,879 | 19.5 K to 14.9 K (-23.50 %) |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | M | 0.00 | 11,700 | 0 | 19,450 | 7.8 K to 19.5 K (+150.97 %) |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 0.00 | 6,300 | 0 | 18,900 | |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Payment of Exercise | F | 47.32 | 3,123 | 147,780 | 12,867 | 16 K to 12.9 K (-19.53 %) |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 0.00 | 6,300 | 0 | 15,990 | 9.7 K to 16 K (+65.02 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 35.60 | 30,000 | 1,068,000 | 100,000 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 35.60 | 30,000 | 1,068,000 | 100,000 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 14.60 | 10,000 | 146,000 | 89,500 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 14.60 | 10,000 | 146,000 | 89,500 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 17.10 | 25,000 | 427,500 | 55,000 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 17.10 | 25,000 | 427,500 | 55,000 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Sell | S | 51.23 | 20,328 | 1,041,501 | 0 | 20.3 K to 0 (-100.00 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Sell | S | 51.23 | 20,328 | 1,041,501 | 0 | 20.3 K to 0 (-100.00 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Sell | S | 50.48 | 44,672 | 2,255,199 | 20,328 | 65 K to 20.3 K (-68.73 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Sell | S | 50.48 | 44,672 | 2,255,199 | 20,328 | 65 K to 20.3 K (-68.73 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 35.60 | 30,000 | 1,068,000 | 65,000 | 35 K to 65 K (+85.71 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 35.60 | 30,000 | 1,068,000 | 65,000 | 35 K to 65 K (+85.71 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 14.60 | 10,000 | 146,000 | 35,000 | 25 K to 35 K (+40.00 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 14.60 | 10,000 | 146,000 | 35,000 | 25 K to 35 K (+40.00 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 17.10 | 25,000 | 427,500 | 25,000 | 0 to 25 K |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 17.10 | 25,000 | 427,500 | 25,000 | 0 to 25 K |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 15.50 | 12,627 | 195,719 | 27,500 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 15.50 | 12,627 | 195,719 | 27,500 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 15.50 | 12,373 | 191,782 | 40,127 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 15.50 | 12,373 | 191,782 | 40,127 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 17.90 | 5,810 | 103,999 | 9,189 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 17.90 | 5,810 | 103,999 | 9,189 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 32.50 | 3,274 | 106,405 | 3,726 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 32.50 | 3,274 | 106,405 | 3,726 | |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 50.28 | 12,627 | 634,873 | 9,690 | 22.3 K to 9.7 K (-56.58 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 50.28 | 12,627 | 634,873 | 9,690 | 22.3 K to 9.7 K (-56.58 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 15.50 | 12,627 | 195,719 | 22,317 | 9.7 K to 22.3 K (+130.31 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 15.50 | 12,627 | 195,719 | 22,317 | 9.7 K to 22.3 K (+130.31 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 51.23 | 10,257 | 525,428 | 9,690 | 19.9 K to 9.7 K (-51.42 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 51.23 | 10,257 | 525,428 | 9,690 | 19.9 K to 9.7 K (-51.42 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 50.48 | 21,200 | 1,070,087 | 19,947 | 41.1 K to 19.9 K (-51.52 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 50.48 | 21,200 | 1,070,087 | 19,947 | 41.1 K to 19.9 K (-51.52 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 15.50 | 12,373 | 191,782 | 41,147 | 28.8 K to 41.1 K (+43.00 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 15.50 | 12,373 | 191,782 | 41,147 | 28.8 K to 41.1 K (+43.00 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 17.90 | 5,810 | 103,999 | 28,774 | 23 K to 28.8 K (+25.30 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 17.90 | 5,810 | 103,999 | 28,774 | 23 K to 28.8 K (+25.30 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 32.50 | 3,274 | 106,405 | 22,964 | 19.7 K to 23 K (+16.63 %) |
Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 32.50 | 3,274 | 106,405 | 22,964 | 19.7 K to 23 K (+16.63 %) |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Option Exercise | A | 56.50 | 5,000 | 282,500 | 5,000 | |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Grant | A | 0.00 | 2,654 | 0 | 14,230 | 11.6 K to 14.2 K (+22.93 %) |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | Soni Manmeet Singh | Director | Option Exercise | A | 56.50 | 5,000 | 282,500 | 5,000 | |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | Soni Manmeet Singh | Director | Sell | S | 56.51 | 133 | 7,516 | 5,087 | 5.2 K to 5.1 K (-2.55 %) |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | Soni Manmeet Singh | Director | Sell | S | 55.82 | 1,084 | 60,506 | 5,220 | 6.3 K to 5.2 K (-17.20 %) |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | Soni Manmeet Singh | Director | Grant | A | 0.00 | 2,654 | 0 | 6,304 | 3.7 K to 6.3 K (+72.71 %) |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Option Exercise | A | 56.50 | 5,000 | 282,500 | 5,000 | |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Grant | A | 0.00 | 2,654 | 0 | 14,130 | 11.5 K to 14.1 K (+23.13 %) |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Option Exercise | A | 56.50 | 5,000 | 282,500 | 5,000 | |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Grant | A | 0.00 | 2,654 | 0 | 5,704 | 3.1 K to 5.7 K (+87.02 %) |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Option Exercise | A | 56.50 | 5,000 | 282,500 | 5,000 | |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Grant | A | 0.00 | 2,654 | 0 | 5,704 | 3.1 K to 5.7 K (+87.02 %) |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | GALLAHUE KIERAN | Director | Option Exercise | A | 56.50 | 5,000 | 282,500 | 5,000 | |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 2,654 | 0 | 7,398 | 4.7 K to 7.4 K (+55.94 %) |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | FETZER OLIVER | Director | Option Exercise | A | 56.50 | 5,000 | 282,500 | 5,000 | |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | FETZER OLIVER | Director | Sell | S | 56.64 | 30 | 1,699 | 4,179 | 4.2 K to 4.2 K (-0.71 %) |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | FETZER OLIVER | Director | Sell | S | 55.88 | 1,495 | 83,539 | 4,209 | 5.7 K to 4.2 K (-26.21 %) |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | FETZER OLIVER | Director | Grant | A | 0.00 | 2,654 | 0 | 5,704 | 3.1 K to 5.7 K (+87.02 %) |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Option Exercise | A | 56.50 | 5,000 | 282,500 | 5,000 | |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Sell | S | 56.51 | 170 | 9,606 | 4,179 | 4.3 K to 4.2 K (-3.91 %) |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Sell | S | 55.82 | 1,355 | 75,634 | 4,349 | 5.7 K to 4.3 K (-23.76 %) |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Grant | A | 0.00 | 2,654 | 0 | 5,704 | 3.1 K to 5.7 K (+87.02 %) |
Mar 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Option Exercise | M | 40.10 | 1,200 | 48,120 | 0 | |
Mar 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Sell | S | 45.99 | 1,200 | 55,183 | 11,476 | 12.7 K to 11.5 K (-9.47 %) |
Mar 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Buy | M | 40.10 | 1,200 | 48,120 | 12,676 | 11.5 K to 12.7 K (+10.46 %) |
Feb 04 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 40.10 | 1,500 | 60,150 | 0 | |
Feb 04 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 46.10 | 1,500 | 69,150 | 19,690 | 21.2 K to 19.7 K (-7.08 %) |
Feb 04 2019 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 40.10 | 1,500 | 60,150 | 21,190 | 19.7 K to 21.2 K (+7.62 %) |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Option Exercise | M | 15.10 | 3,000 | 45,300 | 110,350 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Option Exercise | M | 15.10 | 3,000 | 45,300 | 110,350 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Option Exercise | M | 15.10 | 16,000 | 241,600 | 113,350 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Option Exercise | M | 15.10 | 16,000 | 241,600 | 113,350 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Option Exercise | A | 0.00 | 12,600 | 0 | 12,600 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Option Exercise | A | 0.00 | 12,600 | 0 | 12,600 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Option Exercise | A | 40.94 | 75,000 | 3,070,500 | 75,000 | |
Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Klassen Preston | EVP and CMO | Option Exercise | A | 40.94 | 75,000 | 3,070,500 | 75,000 |